Retatrutide articles
8 articles available.
30mg vs 60mg Retatrutide: what the label actually means
A 60mg Retatrutide product contains twice the stated peptide quantity of a 30mg product, but that does not make it twice as effective or automatically better value. Here is how to read the numbers properly.
Retatrutide dosing: a minimum effective dose guide for research
A research-focused guide to Retatrutide dosing, covering triple agonist effects, slower titration, functional checkpoints and why 12 mg should not be treated as the default target.
Retatrutide Prices in South Africa: A Research Guide Beyond Weight Loss
Retatrutide is an investigational GLP-1/GIP/glucagon receptor tri-agonist studied for weight management, glycaemic control, liver fat reduction and wider metabolic outcomes.
Retatrutide South Africa: More Than Weight Loss
Retatrutide is a triple GLP-1, GIP and glucagon receptor agonist being studied for weight management, glycaemic control, liver fat and wider metabolic health.
Microdosing Retatrutide: Evidence, Risks and Low-Dose Research
Microdosing Retatrutide is widely discussed, but it is not an established clinical protocol. Here is what low-dose research actually supports, and where the evidence stops.
Retatrutide South Africa: What the Research Says Beyond Weight Loss
Retatrutide is best known for major weight-loss results, but research also examines glucose control, liver fat and cardiometabolic markers. The evidence is promising, with important limits.
When More Retatrutide Isn't the Answer: The Factors That Can Affect Weight-Loss Results
Retatrutide is studied for substantial weight loss, but poor results do not always mean more is needed. Nutrition, hydration, training, side effects and product quality all matter.
Retatrutide in South Africa: appetite, satiety and lean-mass considerations
Retatrutide is being studied for weight management and diabetes through a triple agonist mechanism. This guide explains why appetite suppression is only part of the research discussion.